In The News
In 2023, artificial intelligence (AI) truly entered our daily lives. The latest data shows four in five teenagers in the United Kingdom are using generative AI tools. About two-thirds of Australian employees report using generative AI for work.
This past year marked major advances in generative AI as terms like ChatGPT and Bard become household names. Companies sank major investment into AI startups (Microsoft’s $10 billion drop into OpenAI, Amazon’s $4 billion to Anthropic to name just two), while leading AI researchers and CEOs debated AGI’s likelihood in headlines.
Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest for a novel cancer treatment.